0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Animal Biopharma Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-7R15126
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Animal Biopharma Market Insights Forecast to 2029
BUY CHAPTERS

Global Animal Biopharma Market Research Report 2025

Code: QYRE-Auto-7R15126
Report
January 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Animal Biopharma Market Size

According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%.

Animal Biopharma Market

Animal Biopharma Market

The global market for Animal Biopharma was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 143%.
This report aims to provide a comprehensive presentation of the global market for Animal Biopharma, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Biopharma.
The Animal Biopharma market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Animal Biopharma market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Animal Biopharma companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Animal Biopharma Market Report

Report Metric Details
Report Name Animal Biopharma Market
Accounted market size in 2022 $ 261 billion
Base Year 2022
Segment by Type
Segment by Application
  • Prevention
  • Treatment
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac, Ceva, Vetoquinol
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Animal Biopharma company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Animal Biopharma Market report?

Ans: The main players in the Animal Biopharma Market are Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac, Ceva, Vetoquinol

What are the Application segmentation covered in the Animal Biopharma Market report?

Ans: The Applications covered in the Animal Biopharma Market report are Prevention, Treatment

What are the Type segmentation covered in the Animal Biopharma Market report?

Ans: The Types covered in the Animal Biopharma Market report are Vaccine (Bacteria), Immune Serum, Antigen & Antibody, Others

Recommended Reports

Pet Health Solutions

Veterinary Diagnostics

Animal Nutrition

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Animal Biopharma Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Vaccine (Bacteria)
1.2.3 Immune Serum
1.2.4 Antigen & Antibody
1.2.5 Others
1.3 Market by Application
1.3.1 Global Animal Biopharma Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Prevention
1.3.3 Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Animal Biopharma Market Perspective (2020-2031)
2.2 Global Animal Biopharma Growth Trends by Region
2.2.1 Global Animal Biopharma Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Animal Biopharma Historic Market Size by Region (2020-2025)
2.2.3 Animal Biopharma Forecasted Market Size by Region (2026-2031)
2.3 Animal Biopharma Market Dynamics
2.3.1 Animal Biopharma Industry Trends
2.3.2 Animal Biopharma Market Drivers
2.3.3 Animal Biopharma Market Challenges
2.3.4 Animal Biopharma Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Animal Biopharma Players by Revenue
3.1.1 Global Top Animal Biopharma Players by Revenue (2020-2025)
3.1.2 Global Animal Biopharma Revenue Market Share by Players (2020-2025)
3.2 Global Animal Biopharma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Animal Biopharma Revenue
3.4 Global Animal Biopharma Market Concentration Ratio
3.4.1 Global Animal Biopharma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Animal Biopharma Revenue in 2024
3.5 Global Key Players of Animal Biopharma Head office and Area Served
3.6 Global Key Players of Animal Biopharma, Product and Application
3.7 Global Key Players of Animal Biopharma, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Animal Biopharma Breakdown Data by Type
4.1 Global Animal Biopharma Historic Market Size by Type (2020-2025)
4.2 Global Animal Biopharma Forecasted Market Size by Type (2026-2031)
5 Animal Biopharma Breakdown Data by Application
5.1 Global Animal Biopharma Historic Market Size by Application (2020-2025)
5.2 Global Animal Biopharma Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Animal Biopharma Market Size (2020-2031)
6.2 North America Animal Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Animal Biopharma Market Size by Country (2020-2025)
6.4 North America Animal Biopharma Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Animal Biopharma Market Size (2020-2031)
7.2 Europe Animal Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Animal Biopharma Market Size by Country (2020-2025)
7.4 Europe Animal Biopharma Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Animal Biopharma Market Size (2020-2031)
8.2 Asia-Pacific Animal Biopharma Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Animal Biopharma Market Size by Region (2020-2025)
8.4 Asia-Pacific Animal Biopharma Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Animal Biopharma Market Size (2020-2031)
9.2 Latin America Animal Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Animal Biopharma Market Size by Country (2020-2025)
9.4 Latin America Animal Biopharma Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Animal Biopharma Market Size (2020-2031)
10.2 Middle East & Africa Animal Biopharma Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Animal Biopharma Market Size by Country (2020-2025)
10.4 Middle East & Africa Animal Biopharma Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Details
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Animal Biopharma Introduction
11.1.4 Boehringer Ingelheim Revenue in Animal Biopharma Business (2020-2025)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Invetx
11.2.1 Invetx Company Details
11.2.2 Invetx Business Overview
11.2.3 Invetx Animal Biopharma Introduction
11.2.4 Invetx Revenue in Animal Biopharma Business (2020-2025)
11.2.5 Invetx Recent Development
11.3 CZ Vaccines
11.3.1 CZ Vaccines Company Details
11.3.2 CZ Vaccines Business Overview
11.3.3 CZ Vaccines Animal Biopharma Introduction
11.3.4 CZ Vaccines Revenue in Animal Biopharma Business (2020-2025)
11.3.5 CZ Vaccines Recent Development
11.4 Scout Bio
11.4.1 Scout Bio Company Details
11.4.2 Scout Bio Business Overview
11.4.3 Scout Bio Animal Biopharma Introduction
11.4.4 Scout Bio Revenue in Animal Biopharma Business (2020-2025)
11.4.5 Scout Bio Recent Development
11.5 Zoetis
11.5.1 Zoetis Company Details
11.5.2 Zoetis Business Overview
11.5.3 Zoetis Animal Biopharma Introduction
11.5.4 Zoetis Revenue in Animal Biopharma Business (2020-2025)
11.5.5 Zoetis Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Animal Biopharma Introduction
11.6.4 Merck Revenue in Animal Biopharma Business (2020-2025)
11.6.5 Merck Recent Development
11.7 Elanco
11.7.1 Elanco Company Details
11.7.2 Elanco Business Overview
11.7.3 Elanco Animal Biopharma Introduction
11.7.4 Elanco Revenue in Animal Biopharma Business (2020-2025)
11.7.5 Elanco Recent Development
11.8 Virbac
11.8.1 Virbac Company Details
11.8.2 Virbac Business Overview
11.8.3 Virbac Animal Biopharma Introduction
11.8.4 Virbac Revenue in Animal Biopharma Business (2020-2025)
11.8.5 Virbac Recent Development
11.9 Ceva
11.9.1 Ceva Company Details
11.9.2 Ceva Business Overview
11.9.3 Ceva Animal Biopharma Introduction
11.9.4 Ceva Revenue in Animal Biopharma Business (2020-2025)
11.9.5 Ceva Recent Development
11.10 Vetoquinol
11.10.1 Vetoquinol Company Details
11.10.2 Vetoquinol Business Overview
11.10.3 Vetoquinol Animal Biopharma Introduction
11.10.4 Vetoquinol Revenue in Animal Biopharma Business (2020-2025)
11.10.5 Vetoquinol Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Animal Biopharma Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Vaccine (Bacteria)
 Table 3. Key Players of Immune Serum
 Table 4. Key Players of Antigen & Antibody
 Table 5. Key Players of Others
 Table 6. Global Animal Biopharma Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Animal Biopharma Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Animal Biopharma Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Animal Biopharma Market Share by Region (2020-2025)
 Table 10. Global Animal Biopharma Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Animal Biopharma Market Share by Region (2026-2031)
 Table 12. Animal Biopharma Market Trends
 Table 13. Animal Biopharma Market Drivers
 Table 14. Animal Biopharma Market Challenges
 Table 15. Animal Biopharma Market Restraints
 Table 16. Global Animal Biopharma Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Animal Biopharma Market Share by Players (2020-2025)
 Table 18. Global Top Animal Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biopharma as of 2024)
 Table 19. Ranking of Global Top Animal Biopharma Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Animal Biopharma Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Animal Biopharma, Headquarters and Area Served
 Table 22. Global Key Players of Animal Biopharma, Product and Application
 Table 23. Global Key Players of Animal Biopharma, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Animal Biopharma Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Animal Biopharma Revenue Market Share by Type (2020-2025)
 Table 27. Global Animal Biopharma Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Animal Biopharma Revenue Market Share by Type (2026-2031)
 Table 29. Global Animal Biopharma Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Animal Biopharma Revenue Market Share by Application (2020-2025)
 Table 31. Global Animal Biopharma Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Animal Biopharma Revenue Market Share by Application (2026-2031)
 Table 33. North America Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Animal Biopharma Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Animal Biopharma Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Animal Biopharma Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Animal Biopharma Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Animal Biopharma Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Animal Biopharma Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Animal Biopharma Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Animal Biopharma Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Animal Biopharma Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Animal Biopharma Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Animal Biopharma Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Animal Biopharma Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Boehringer Ingelheim Company Details
 Table 49. Boehringer Ingelheim Business Overview
 Table 50. Boehringer Ingelheim Animal Biopharma Product
 Table 51. Boehringer Ingelheim Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 52. Boehringer Ingelheim Recent Development
 Table 53. Invetx Company Details
 Table 54. Invetx Business Overview
 Table 55. Invetx Animal Biopharma Product
 Table 56. Invetx Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 57. Invetx Recent Development
 Table 58. CZ Vaccines Company Details
 Table 59. CZ Vaccines Business Overview
 Table 60. CZ Vaccines Animal Biopharma Product
 Table 61. CZ Vaccines Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 62. CZ Vaccines Recent Development
 Table 63. Scout Bio Company Details
 Table 64. Scout Bio Business Overview
 Table 65. Scout Bio Animal Biopharma Product
 Table 66. Scout Bio Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 67. Scout Bio Recent Development
 Table 68. Zoetis Company Details
 Table 69. Zoetis Business Overview
 Table 70. Zoetis Animal Biopharma Product
 Table 71. Zoetis Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 72. Zoetis Recent Development
 Table 73. Merck Company Details
 Table 74. Merck Business Overview
 Table 75. Merck Animal Biopharma Product
 Table 76. Merck Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 77. Merck Recent Development
 Table 78. Elanco Company Details
 Table 79. Elanco Business Overview
 Table 80. Elanco Animal Biopharma Product
 Table 81. Elanco Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 82. Elanco Recent Development
 Table 83. Virbac Company Details
 Table 84. Virbac Business Overview
 Table 85. Virbac Animal Biopharma Product
 Table 86. Virbac Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 87. Virbac Recent Development
 Table 88. Ceva Company Details
 Table 89. Ceva Business Overview
 Table 90. Ceva Animal Biopharma Product
 Table 91. Ceva Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 92. Ceva Recent Development
 Table 93. Vetoquinol Company Details
 Table 94. Vetoquinol Business Overview
 Table 95. Vetoquinol Animal Biopharma Product
 Table 96. Vetoquinol Revenue in Animal Biopharma Business (2020-2025) & (US$ Million)
 Table 97. Vetoquinol Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Animal Biopharma Picture
 Figure 2. Global Animal Biopharma Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Animal Biopharma Market Share by Type: 2024 VS 2031
 Figure 4. Vaccine (Bacteria) Features
 Figure 5. Immune Serum Features
 Figure 6. Antigen & Antibody Features
 Figure 7. Others Features
 Figure 8. Global Animal Biopharma Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Animal Biopharma Market Share by Application: 2024 VS 2031
 Figure 10. Prevention Case Studies
 Figure 11. Treatment Case Studies
 Figure 12. Animal Biopharma Report Years Considered
 Figure 13. Global Animal Biopharma Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Animal Biopharma Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Animal Biopharma Market Share by Region: 2024 VS 2031
 Figure 16. Global Animal Biopharma Market Share by Players in 2024
 Figure 17. Global Top Animal Biopharma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Biopharma as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Animal Biopharma Revenue in 2024
 Figure 19. North America Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Animal Biopharma Market Share by Country (2020-2031)
 Figure 21. United States Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Animal Biopharma Market Share by Country (2020-2031)
 Figure 25. Germany Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Animal Biopharma Market Share by Region (2020-2031)
 Figure 33. China Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Animal Biopharma Market Share by Country (2020-2031)
 Figure 41. Mexico Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Animal Biopharma Market Share by Country (2020-2031)
 Figure 45. Turkey Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Animal Biopharma Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Boehringer Ingelheim Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 49. Invetx Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 50. CZ Vaccines Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 51. Scout Bio Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 52. Zoetis Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 53. Merck Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 54. Elanco Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 55. Virbac Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 56. Ceva Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 57. Vetoquinol Revenue Growth Rate in Animal Biopharma Business (2020-2025)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart